Precigen is trading at $6.36, up 4.52%, with no clear company-specific news explaining the gain in available coverage.
- Precigen announced on October 28 that it will report third-quarter results and provide business updates on November 4; the scheduled event does not establish the reason for the October 29 move.
- The broader market is lower, so the provided market context does not explain the stock’s rise.
- Trading volume information was not available in the supplied price context.